Literature DB >> 3185367

Ototoxicity of high-dose cis-platinum in children.

P Brock1, J Pritchard, S Bellman, C R Pinkerton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3185367     DOI： 10.1002/mpo.2950160517

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN： 0098-1532


× No keyword cloud information.
  14 in total

Review 1.  Drug-Induced Ototoxicity: Diagnosis and Monitoring.

Authors:  Kathleen C M Campbell; Colleen G Le Prell
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

2.  Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: report from the Children's Oncology Group.

Authors:  Amulya A Nageswara Rao; Dana J Wallace; Catherine Billups; James M Boyett; Amar Gajjar; Roger J Packer
Journal:  Pediatr Blood Cancer       Date:  2013-08-19       Impact factor: 3.167

3.  Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting.

Authors:  Nancy D Doolittle; David M Peereboom; Gregory A Christoforidis; Walter A Hall; Diane Palmieri; Penelope R Brock; Kathleen C M Campbell; D Thomas Dickey; Leslie L Muldoon; Brian Patrick O'Neill; Darryl R Peterson; Brad Pollock; Carole Soussain; Quentin Smith; Rose Marie Tyson; Edward A Neuwelt
Journal:  J Neurooncol       Date:  2006-07-21       Impact factor: 4.130

Review 4.  Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.

Authors:  Penelope R Brock; Kristin R Knight; David R Freyer; Kathleen C M Campbell; Peter S Steyger; Brian W Blakley; Shahrad R Rassekh; Kay W Chang; Brian J Fligor; Kaukab Rajput; Michael Sullivan; Edward A Neuwelt
Journal:  J Clin Oncol       Date:  2012-04-30       Impact factor: 44.544

5.  Prohibitive toxicity of a dose-intense regime for metastatic neuroblastoma containing ifosfamide, doxorubicin and cisplatin.

Authors:  S P Lowis; A D Pearson; M M Reid; A W Craft
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Cisplatin therapy in infants: short and long-term morbidity.

Authors:  P R Brock; E C Yeomans; S C Bellman; J Pritchard
Journal:  Br J Cancer Suppl       Date:  1992-08

7.  Determining the prevalence of vestibular screening failures in pediatric cancer patients whose therapies include radiation to the head/neck and platin-based therapies: A pilot study.

Authors:  Miranda L Camet; Susan S Hayashi; Belinda C Sinks; Jennifer Henry; Katie Gettinger; Ashley Hite; Juliann Kiefer; Caroline Mohrmann; Taryn Sandheinrich; Feng Gao; Robert J Hayashi
Journal:  Pediatr Blood Cancer       Date:  2018-01-30       Impact factor: 3.167

Review 8.  Drug-induced ototoxicity. Pathogenesis and prevention.

Authors:  M Y Huang; J Schacht
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

9.  Reirradiation of Recurrent Pediatric Brain Tumors after Initial Proton Therapy.

Authors:  Benjamin Farnia; Nancy Philip; Rola H Georges; Mary Frances McAleer; Matthew Palmer; Jinzhong Yang; Pamela K Allen; Mary K Martel; Anita Mahajan; Susan L McGovern
Journal:  Int J Part Ther       Date:  2016-08-29

10.  Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy.

Authors:  Benjamin J Moeller; Murali Chintagumpala; Jimmy J Philip; David R Grosshans; Mary F McAleer; Shiao Y Woo; Paul W Gidley; Tribhawan S Vats; Anita Mahajan
Journal:  Radiat Oncol       Date:  2011-06-02       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.